Status | Study |
Completed |
Study Name: A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ Condition: Ductal Carcinoma in Situ Date: 2012-06-20 Interventions: Dietary Supplement: Black cohosh Remifemin 20 mg tablet orally twice per day x 4 weeks |
Terminated |
Study Name: Diagnostic Study of Early Breast Cancer Using Ultrasound Condition: Ductal Carcinoma In-situ Date: 2011-06-15 Interventions: Drug: Perflutren lipid microsphere Intravenous injection of 10 microL/kg once prior to ultrasound examin |
Completed |
Study Name: Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) Condition: Carcinoma in Situ Bladder Cancer Date: 2011-03-15 Interventions: Drug: Valrubicin, 800 mg Investigator will be responsible for regulating the use of concomitant medicati |
Terminated |
Study Name: Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder Condition: Carcinoma in Situ Transitional Cell Carcinoma Date: 2011-03-04 Interventions: Drug: VALSTAR - Maintenance Therapy |
Completed |
Study Name: Retrospective Chart Review of Valstar Condition: Carcinoma in Situ of Bladder Date: 2011-02-23 |
Terminated |
Study Name: A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ Condition: Ductal Carcinoma in Situ Date: 2010-01-29 Interventions: Drug: Polyphenon E three 200mg capsules (600mg total dose of the study drug) with food (within one hour |
Completed |
Study Name: 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ Condition: Ductal Breast Carcinoma in Situ Estrogen Receptor-positive Brea Date: 2009-08-04 Interventions: Drug: oral placebo Oral placeb |
Active, not recruiting |
Study Name: Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers Condition: Breast Cancer Date: 2009-07-07 Interventions: Genetic: DNA analysis Genetic: polymorphis |
Completed |
Study Name: MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ Condition: Breast Cancer Date: 2009-04-01 Interventions: Procedure: magnetic resonance imaging Proc |
Terminated |
Study Name: Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast Condition: Ductal Carcinoma in Situ Date: 2009-03-06 Interventions: Drug: lapatinib 1500 mg lapatinib for 14-21 days Oth |